BEAM logo

BEAMBeam Therapeutics Inc

$31.09
$0.10
(0.32%)
Pre-Market
Updated: 04:36 AM EDT·Prev Close $30.99
EarningsAug 4
Mkt Cap$3.2B
Vol595.00

About

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
511

Frequently Asked Questions

What is Market Cap of Beam Therapeutics Inc?
What is the 52-week high for Beam Therapeutics Inc?
What is the 52-week low for Beam Therapeutics Inc?
What is Beam Therapeutics Inc stock price today?
What was Beam Therapeutics Inc stock price yesterday?
What is the PE ratio of Beam Therapeutics Inc?
What is the Price-to-Book ratio of Beam Therapeutics Inc?
What is the 50-day moving average of Beam Therapeutics Inc?
How many employees does Beam Therapeutics Inc have?

Advertisement|Remove ads.